Published in Gene Therapy Weekly, October 19th, 2000
"Numerous advances have been made in gene therapy approaches for the treatment of solid tumors, including prostate cancer," wrote J.A. Eastham and colleagues, Louisiana State University. "While treatment of the primary tumor has been well investigated, little information is available regarding gene therapy techniques which might impact on the progression to metastatic disease. We investigate the ability of p53 adenovirus to suppress not only primary tumor growth, but also the progression...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.